Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2015 / Article
Special Issue

Oxidative Stress in Disease and Aging: Mechanisms and Therapies

View this Special Issue

Research Article | Open Access

Volume 2015 |Article ID 682861 | 9 pages | https://doi.org/10.1155/2015/682861

Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells

Academic Editor: Claudio Cabello-Verrugio
Received12 Nov 2014
Revised10 Jan 2015
Accepted17 Jan 2015
Published20 Oct 2015

Abstract

MUTYH is a DNA repair enzyme that initiates a base excision repair (BER) by recognizing and removing 8-Oxoguanine (8-oxoG) and its paired adenine. We demonstrated that both TGF-β1 and H2O2 treatment led to an increased 8-oxoG in cultured human proximal tubule epithelial (HK-2) cells, while the former induced epithelial-mesenchymal transition and the latter caused cell apoptosis. Without stimulation, HK-2 cells showed MUTYH expression in mitochondria. TGF-β1 triggered a transient upregulation of mitochondrial MUTYH and induced the expression of nuclear isoforms, while H2O2 showed no role on MUTYH expression. Ureteral obstruction (UUO) mice exhibited high 8-oxoG reactivity with tubulointerstitial lesions. After obstruction, the MUTYH expression was increased only in tubules at day 3 and decreased with obvious tubular atrophy at day 10. Particularly, MUTYH was primarily located in normal tubular cytoplasm with a dominant mitochondrial form. A few cells with nuclear MUTYH expression were observed in the fibrotic interstitium. We confirmed that increased MUTYH expression was upregulated and positively correlated with the severity of kidney fibrosis. Thus, renal fibrosis caused a cell-type-specific and time-dependent response of oxidative DNA repairs, even within the same tissues. It suggests that intervention of MUTYH might be effective for therapies.

1. Introduction

Renal fibrosis occurs in many forms of chronic kidney disease progressing to end-stage renal disorders (ESRD) [1]. Oxidative stress in kidneys is often suggested to contribute to interstitial fibrosis [2]. DNA is one of the most important biological targets of oxidative stress, and oxidative DNA lesions are a major type of endogenous damage leading to human disorders. The most stable product of oxidative DNA damage is 8-Oxoguanine (8-oxoG) [3, 4], and 8-oxoG has been observed in kidneys in several conditions.

Adenine can pair with 8-oxoG in double-stranded DNA, leading to mispairing during genome replication [5]. If the mismatch is not repaired, the G: C to T: A mutation will be inherited in future cell cycles. Mammalian cells are equipped with elaborate means to minimize 8-oxoG accumulation in DNA [6, 7]. The human MutY homolog (MUTYH) initiates a base excision repair (BER) by recognizing and removing 8-oxoG and its paired adenine. Mutated BER proteins are reported to increase the risk of accumulating 8-oxoG in mitochondrial DNA (mtDNA) as well as nuclear DNA (nDNA). Mutant mice lacking MUTYH exhibit increased spontaneous mutation rates and susceptibility to carcinogenesis, with increased accumulation of 8-oxoG in DNA.

Oxidative stress is important in the etiology of several renal disorders, and 8-oxoG levels are increased in the kidneys of patients with several diseases, including diabetic nephropathy (DN) [8]. We therefore explored the possible association between MUTYH and ESRD and showed an increased risk of germline MUTYH polymorphisms during ESRD development [9]. This implied that MUTYH might be implicated in the pathogenesis of renal fibrosis. However, how this enzyme influences fibrosis is poorly understood. In addition, there are more than ten splice variants in mammalian cells [10], which localize to either nuclei or mitochondria. The 52 or 53 kDa MUTYH variant is generally localized in nuclei, whereas the 57 kDa MUTYH form localizes in mitochondria. The two forms are involved in distinct signaling pathways. The exact MUTYH form involved in renal fibrosis is not yet known.

Unilateral ureteral obstruction (UUO) is a widely used in vivo model of renal fibrosis [11]. It is a good example of the role of epithelial-mesenchymal transition (EMT) and renal oxidative stress in chronic progressive renal disease. The tubular epithelial cells play a key role in this process, and the immortalized HK-2 cell line is often used to study the mechanism of renal fibrosis in vitro [12]. Transforming growth factor-β1 (TGF-β1) induced EMT and hydrogen peroxide induced renal tubular cell apoptosis were used to study the association with MUTYH. The in vivo and in vitro responses of MUTYH (mitochondrial and/or nuclear forms) in renal fibrosis were investigated in the present study.

2. Materials and Methods

2.1. Reagents

The primary antibodies used in this study were mouse monoclonal anti-8-oxoG (JaICA, Shizuoka, Japan); rabbit anti-MUTYH (BS2535, Bioworld Technology); mouse monoclonal anti-alpha smooth muscle actin (ab119952, Abcam); and anti-GAPDH (AP0066, Bioworld Technology). Recombinant human transforming growth factor beta-1 (TGF-β1) was purchased from R&D (240-B-010, R&D Systems).

2.2. Patients and Materials

Needle biopsies from renal tissues were analyzed in the present study. The patients with diabetic nephrology (DN) were randomly chosen from the Biobank of the National Clinical Research Center of Kidney Diseases, Jinling Hospital. The biopsy specimens were processed according to standard procedures and divided into two groups according to the tubular atrophy (IFTA) scores [13]. The mild renal fibrosis group () was defined as Grades 0~1 and the severe group () as Grades 2~3. The study protocol was approved by the Ethics Committee of Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

For the UUO models, C57BL/6 mice (8 weeks old, male) were purchased from the Experimental Laboratory of Animal Models (Nanjing, China). The test group was anesthetized and the left ureter was ligated (UUO group, ), while controls were anesthetized and manipulated without ligation (sham group, ). The study was approved by the Institutional Animal Care and Use Committee of Nanjing University School of Medicine.

Injured tubular cells were further investigated using two in vitro models. Immortalized proximal tubular epithelial cells from the normal adult human kidney (HK-2) were cultured in DMEM/F12 medium (1 : 1, Gibco) supplemented with 10% FBS. In one model, HK-2 cells were treated with 5 ng/mL of recombinant TGF-β1 for 24 h, 48 h, and 72 h, as previously described [14]. In the other model, HK-2 cells were incubated with 0.5 mM hydrogen peroxide (H2O2) for 1 h or 3 h [15]. Control cells were treated with vehicle medium for the same times. All experiments were performed in triplicate.

2.3. Histological Analysis

The kidney samples were fixed in 10% formaldehyde, embedded in paraffin, cut into 4 μm sections, and subjected to periodic acid-Schiff (PAS) and Masson Trichrome staining. The pathological changes were observed under a light microscope. Photographs were obtained, and morphology was quantitatively analyzed using the Image-Pro Plus system (Media Cybernetics). The percentage of interstitial collagen deposition was calculated in renal fibrosis [16], and an average of 20 visual fields of each sample was evaluated.

Other kidney sections were used for immunohistochemical analysis. After heat-induced antigen unmasking, sections were incubated with anti-MUTYH antibody or anti-alpha smooth muscle actin antibody for 16 h at 4°C, followed by incubation with secondary antibodies labeled for detection. Other free-floating sections were pretreated as described previously [17] and subjected to 8-oxoG immunodetection in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). The immunofluorescence images were photographed using a laser scanning confocal microscopy (Zeiss) and the immunohistochemistry slides were recorded using a Nikon light microscope (Nikon Inc). Semiquantitative analysis of MUYTH or 8-oxoG expression was evaluated using the Image-Pro Plus system. The integrated optical density (IOD) in tubules was examined for at least 20 consecutive microscopic fields each section. The percentage of tubules with MUTYH immunoreactivity was also evaluated in a mean (+SE) of 281 (+11) tubules.

2.4. Immunofluorescent Analysis In Vitro

The cultured HK-2 cells were first washed with PBS and fixed in 4% paraformaldehyde for 20 min at 4°C. Following three washes with PBS (5 min each), cells were permeabilized with 0.5% Triton X-100 for 10 min, blocked in 5% BSA for 30 min, and incubated overnight at 4°C with and anti-MUTYH or anti-8-oxoG antibody in PBS in a dark chamber, followed by secondary antibody incubation. The special pretreatment for 8-oxoG staining was conducted as previously described [17]. Before the addition of a coverslip, the cell slides were incubated with 2 mM DAPI (D1306, Molecular Probes). Fluorescent images were examined by laser scanning confocal microscopy.

2.5. TUNEL Analysis

The terminal deoxynucleotidyl transferase-mediated UTP nick end labeling (TUNEL) staining was analyzed with a DNA fragmentation detection kit (11684817910, Roche Corp) according to the manufacturer’s instructions. The positive apoptotic cells were detected, and the apoptotic index was calculated as the ratio of positive apoptotic cardiocytes to total number of HK-2 cells. A mean (+SE) of 961 (+147) cells was counted for analysis.

2.6. Western Blot Analysis

The kidney tissue and cells were lysed on ice for 30 min using RIPA lysis buffer (P002A, AURAGENE). After boiling with loading buffer, 30 μg of extracted protein was subjected to SDS-PAGE and transferred to PVDF (polyvinyl difluoride) membranes (IPVH00010, Millipore). After blocking the nonspecific binding sites, the primary antibodies rabbit anti-MutY and mouse monoclonal anti-alpha smooth muscle actin were incubated at 4°C overnight, followed by incubation with an HRP-labeled secondary antibody. The bands were detected with an enhanced chemiluminescent reagent (Millipore), and specific ~57 kDa and ~53 kDa bands for MUTYH were observed. Relevant bands were quantified by densitometry using Image J, background corrected and normalized to GAPDH levels.

2.7. Statistical Analysis

Data were shown as the mean ± SD and analyzed using SPSS version 13.0. Comparisons were performed using Student’s -test for two groups or ANOVA (one-way analysis of variance) for three groups, and a nonparametric test was used when necessary. Two-tailed values less than 0.05 were considered statistically significant.

3. Results

3.1. Regulation of MUTYH in Two Models In Vitro

To explore the response of MUTYH in renal fibrosis in vitro, we analyzed HK-2 cells treated by H2O2 and TGF-β1 [2]. With both H2O2 and TGF-β1 treatments, HK-2 cells showed higher 8-oxoG expression compared with vehicle controls (Figure 1(a)). The immunoreactivity of 8-oxoG was mainly located in HK-2 cell mitochondria and only partly in nuclei.

Different cell responses were observed after H2O2 or TGF-β1 treatment. H2O2 leads to cell apoptosis, and the percentage of apoptotic cells increased significantly after incubation with 0.5 mM H2O2 for 1 h and 3 h (Figure 1(b)). TGF-β1 only slightly increased cell apoptosis after treatment for 24 h or 48 h (). However, α-SMA expression increased in HK-2 cells after 24 to 72 h of TGF-β1 treatment (Figure 1(c)). The expression of α-SMA was unchanged by H2O2 treatment. These findings suggested that HK-2 cells respond to H2O2 by cell apoptosis and to TGF-β1 by EMT.

H2O2 and TGF-β1 also showed diverse regulation of MUTYH in HK-2 cells (Figure 2). In the vehicle group, HK-2 cells had high mitochondrial MUTYH expression (Figure 2(a), top line) and ~57 kDa bands in Western blotting (Figures 2(b) and 2(c)). After H2O2 treatment, similar mitochondrial expression was detected in HK-2 cells (Figure 2(a), second line), and semiquantitative analysis demonstrated equal MUTYH expression compared with controls (Figure 2(b)). TGF-β1 treatment induced HK-2 cells from a cobblestone-like morphology to a spindle-like morphology, and MUTYH immunoreactivity was located in nuclei (Figure 2(a)). After TGF-β1 treatment for 72 h, almost all of the cells demonstrated nuclear MUTYH (Figure 2(a), last line). Western blotting analysis confirmed increased 53 kDa nuclear MUTYH and decreased 57 kDa mitochondrial MUTYH in HK-2 cells after TGF-β1 treatment. The concentration of both mitochondrial and nuclear MUTYH in HK-2 cells was also upregulated by TGF-β1 in 24 hours (, Figure 2(c)).

3.2. MUTYH Expression In Vivo Kidney of UUO Mice

The UUO mice at 3 and 10 days after the operation showed proximal tubule dilation, atrophy, and extracellular matrix (ECM) accumulation as a result of collagen deposition. The typical lesions of obstructed kidneys are demonstrated in Figures 3(a) and 3(b). The interstitial collagen deposition was significantly higher in UUO mice than sham-operated kidneys (, ANOVA; Figure 3(c)). The 8-oxoG staining was undetectable in sham-operated kidneys, while oxidative DNA lesions were observed in UUO kidneys (Figure 3(d)). The intensity of 8-oxoG staining significantly increased by Day 3 in obstructed kidneys and was even greater at Day 10 (, ANOVA; Figure 3(e)) when compared with the shams.

MUTYH immunoreactivity can be observed in sham-operated kidneys, and this increased in some tubules in UUO kidneys but did not in interstitium (Figure 4(a)). The MUTYH density in positive tubules was increased significantly in UUO kidney at Day 3 when compared with sham controls, and percentage of positive tubules was also increased (Figure 4(b)). However, the density of MUTYH and the percentage of positive tubules declined in UUO kidneys between Day 3 and Day 10. Particularly, the great MUTYH staining was observed in the residual obstructed tubules at Day 10, but the number of the residual tubules was decreased compared with sham or Day 3 groups (Figure 4(a), the right panel). It suggested that injured tubules presented increased MUTYH expression, while atrophic ones lost its expression. As injured and atrophic tubules were observed at same time, Western blotting only showed slightly increased MUTYH expression in UUO kidneys at Day 3 and then followed by a decrease at Day 10 (Figure 4(c)).

Moreover, the MUTYH bands were mainly at ~57 kDa (Figure 4(c)), suggesting that the mitochondrial form of MUTYH was mainly expressed in kidney. Correspondingly, the immunofluorescent images showed that MUTYH was mainly located in the cytoplasm of renal tubular epithelial cells (Figure 4(d), upper line), where α-SMA was not highly expressed. In fibrotic UUO kidneys, the expression of α-SMA increased in the interstitium, and expression of nuclear MUTYH in a few cells was also observed (Figure 4(d), lower line).

3.3. MUTYH Immunoreactivity in Human Kidneys

Diabetic nephropathy (DN) is a common kidney disease, presenting with glomerular lesions and tubulointerstitial fibrosis. Kidney samples were divided into two groups: mild renal fibrosis (Figure 5(a)) and severe renal fibrosis (Figure 5(b)). In subjects with mild fibrosis, MUTYH immunoreactivity was observed in renal tubule epithelium (Figure 5(c)), but not in the glomeruli or the interstitium (Figure 5(d)). In kidneys with severe fibrosis, the tubule epithelium showed intense MUTYH immunostaining (Figure 5(e)), while cells in glomeruli and interstitial spaces were rarely observed (not shown). The MUTYH intensity in tubules significantly increased with the degree of renal fibrosis (, Figure 5(f)).

4. Discussion

In kidneys, accumulating evidence has demonstrated that kidney fibrosis induced by renal diseases, including diabetic nephropathy, is mediated by ROS/oxidative stress [2, 18, 19]. MUTYH is a well-known oxidative DNA repair enzyme which initiates DNA oxidative damage repair by recognizing A:8-oxoG mismatches and removing the mispaired A. This study demonstrated that expression of MUTYH is regulated in renal tubular epithelial cells from renal fibrosis, suggesting that oxidative DNA repair is involved in this process. The mitochondrial isoform of MUTYH was dominant in kidney and acted in a cell-type-specific manner, even within the same tissue type. Additionally, our data demonstrated that upregulation of MUTYH began at an earlier stage after obstruction injury and was sustained with tubular atrophy. This implied that oxidative DNA repair pathway was involved in the renal fibrosis.

MUTYH expression in kidney tubules was shown in patients with DN. Increased MUTYH expression was associated with the severity of renal fibrosis. Detailed information was obtained from UUO models in vivo. Murine UUO is a frequently used model of progressive renal injury and fibrosis [20]. In obstructed kidneys, increased MUTYH expression was detected in tubule cells compared with sham-operated kidneys.

We observed an interesting pattern of MUTYH staining with immunohistochemistry analysis. At early stage of lesions, MUTYH expression was increased in tubular cells, while it was decreased with tubular atrophy. The MUTYH expression in interstitial cells seemed not to respond to obstruction injury. It suggested that MUTYH expression in UUO performed a cell-type-specific and stage-dependent response under obstruction injury. Such inconsistence with the same tissues and timely response of expression would result in light change in whole kidney at a specific time, when analyzed by Western blotting analysis. Kim et al. [21] also demonstrated that ROS was harmful, playing a role in proliferation and death in a cell-type-specific way in tubule cells, but not in interstitial cells.

The 8-oxoG lesion is a major marker of oxidative damage and is associated with the progression of renal fibrosis. Antioxidative treatment or blockage of specific pathways will therefore attenuate the fibrotic progress [22]. In the present study, we confirmed that 8-oxoG levels increased in UUO kidneys, related with the severity of renal fibrosis. However, oxidative DNA damage did not parallel MUTYH regulation in the kidney. The 8-oxoG staining increased in both tubule epithelial cells and interstitial cells, whereas MUTYH upregulation was only detected in tubules. Epithelial-mesenchymal transition (EMT) and apoptosis of tubule epithelial cells are two major contributors to renal fibrosis [23]. EMT and apoptosis were induced in vitro by TGF-β1 and H2O2, respectively. Both H2O2 stimulation and TGF-β1 stimulation induced increased 8-oxoG in HK-2 cells. However, only TGF-β1 treatment leads to MUTYH upregulation. H2O2, a powerful source of ROS, had no effect on MUTYH expression. These inconsistencies implied that mechanisms in addition to the oxidative DNA damage underlying renal fibrosis were involved in MUTYH regulation.

Moreover, MUTYH has different forms that localize to mitochondria and nuclei, with relative molecular masses of ~57 kDa and ~53 kDa, respectively [10]. During kidney fibrosis, 8-oxoG concentrations increased in both nuclei and mitochondria, and the mitochondrial 8-oxoG was dominant. Similarly, MUYTH was detected in tubule epithelial cell cytoplasm, and increased mitochondrial MUTYH was related to renal fibrosis. Induced expression of nuclear MUTYH was also observed in the fibrotic area labeled by a-SMA staining, but only a few cells were detected in vivo. Interestingly, when TGF-β1 induced EMT in HK-2 cells, the dominant MUTYH form changed from mitochondrial to nuclear. This finding suggested that both mitochondrial and nuclear forms of MUTYH were involved in renal fibrosis. They seemed to play distinct roles in tubule cell injury, but more evidence is needed.

An accumulation of 8-oxoG and upregulation of MUTYH were observed in tumor tissues [24]. Dysfunction of MUTYH leading to accumulative 8-oxoG and subsequently mutation was previously considered to perform role of disease. Recently, MUTYH triggered single-strand breaks (SSBs) in DNA were suggested to aggravate brain damage and promote neurodegeneration [25]. Suppression of MUTYH may even be protective under oxidative stress. To understand the association of MUTYH polymorphisms with renal fibrosis and ESRD [9], the present study demonstrated MUTYH upregulation in kidneys, which might be involved in EMT in renal fibrosis. Additionally, the oxidative DNA damage might not be the only trigger for MUTYH regulation. Although the results in the present study could not demonstrate the role of MUTYH on renal fibrosis, the significance of this study is by the first time to illustrate the association between MUTYH regulation and renal obstruction. The present study is fundamental for further studies, and our ongoing studies showed that MUTYH deficiency protects mice from renal fibrosis (data not shown). The underlying mechanism concerning SSBs and EMT is being investigated.

Taken together, our results demonstrated the regulation of MUTYH in tubule cells in renal fibrosis. Renal fibrosis caused a cell-type-specific and time-dependent response of oxidative DNA repairs, even within the same tissues. There are several reports on MUTYH in cancer research, but few on renal diseases. To our knowledge, this is the first report to describe MUTYH in the kidneys, and it provides a new insight into renal fibrosis. More studies will focus on the regulatory role of MUTYH in the kidney and provide target validation for therapeutic strategies.

Disclosure

The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (81370788, 81100490), the “Six Major Talent Peaks” of Jiangsu Province (WSN-071-2012), and the Returned Overseas Chinese Scholars, State Education Ministry (to Chen Huimei).

References

  1. Y. Liu, “Cellular and molecular mechanisms of renal fibrosis,” Nature Reviews Nephrology, vol. 7, no. 12, pp. 684–696, 2011. View at: Publisher Site | Google Scholar
  2. J. L. Barnes and Y. Gorin, “Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases,” Kidney International, vol. 79, no. 9, pp. 944–956, 2011. View at: Publisher Site | Google Scholar
  3. H. Kasai, “Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis,” Free Radical Biology and Medicine, vol. 33, no. 4, pp. 450–456, 2002. View at: Publisher Site | Google Scholar
  4. H. Kasai and S. Nishimura, “Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents,” Nucleic Acids Research, vol. 12, no. 4, pp. 2137–2145, 1984. View at: Publisher Site | Google Scholar
  5. N. Al-Tassan, N. H. Chmiel, J. Maynard et al., “Inherited variants of MYH associated with somatic G:C–>T: a mutations in colorectal tumors,” Nature Genetics, vol. 30, no. 2, pp. 227–232, 2002. View at: Google Scholar
  6. M. Furuichi, M. C. Yoshida, H. Oda et al., “Genomic structure and chromosome location of the human mutT homologue gene MTH1 encoding 8-oxo-dGTPase for prevention of A:T to C:G transversion,” Genomics, vol. 24, no. 3, pp. 485–490, 1994. View at: Publisher Site | Google Scholar
  7. K. Sakumi, M. Furuichi, T. Tsuzuki et al., “Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-Oxo-dGTP, a mutagenic substrate for DNA synthesis,” The Journal of Biological Chemistry, vol. 268, no. 31, pp. 23524–23530, 1993. View at: Google Scholar
  8. M. Sedeek, R. Nasrallah, R. M. Touyz, and R. L. Hébert, “NADPH oxidases, reactive oxygen species, and the kidney: friend and foe,” Journal of the American Society of Nephrology, vol. 24, no. 10, pp. 1512–1518, 2013. View at: Publisher Site | Google Scholar
  9. Z. Cai, H. Chen, J. Tao et al., “Association of base excision repair gene polymorphisms with ESRD risk in a Chinese population,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 928421, 10 pages, 2012. View at: Publisher Site | Google Scholar
  10. T. Ohtsubo, K. Nishioka, Y. Imaiso et al., “Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria,” Nucleic Acids Research, vol. 28, no. 6, pp. 1355–1364, 2000. View at: Publisher Site | Google Scholar
  11. H. Kaneto, J. Morrissey, and S. Klahr, “Increased expression of TGF-beta1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation,” Kidney International, vol. 44, no. 2, pp. 313–321, 1993. View at: Publisher Site | Google Scholar
  12. J. W. G. V. Copeland, B. W. Beaumont, M. J. Merrilees, and H. L. Pilmore, “Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone,” Transplantation, vol. 83, no. 6, pp. 809–814, 2007. View at: Publisher Site | Google Scholar
  13. K. Solez, R. B. Colvin, L. C. Racusen et al., “Banff 07 classification of renal allograft pathology: updates and future directions,” American Journal of Transplantation, vol. 8, no. 4, pp. 753–760, 2008. View at: Publisher Site | Google Scholar
  14. J. S. J. Gerritsma, C. van Kooten, A. F. Gerritsen, L. A. van Es, and M. R. Daha, “Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells,” Kidney International, vol. 53, no. 3, pp. 609–616, 1998. View at: Publisher Site | Google Scholar
  15. E. J. Sharples, N. Patel, P. Brown et al., “Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2115–2124, 2004. View at: Publisher Site | Google Scholar
  16. M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, and M.-J. Tang, “Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis,” Kidney International, vol. 69, no. 11, pp. 2029–2036, 2006. View at: Publisher Site | Google Scholar
  17. M. Ohno, S. Oka, and Y. Nakabeppu, “Quantitative analysis of oxidized guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method,” Methods in Molecular Biology, vol. 554, pp. 199–212, 2009. View at: Publisher Site | Google Scholar
  18. J. W. Baynes and S. R. Thorpe, “Role of oxidative stress in diabetic complications: a new perspective on an old paradigm,” Diabetes, vol. 48, no. 1, pp. 1–9, 1999. View at: Publisher Site | Google Scholar
  19. A. Dendooven, D. A. Ishola Jr., T. Q. Nguyen et al., “Oxidative stress in obstructive nephropathy,” International Journal of Experimental Pathology, vol. 92, no. 3, pp. 202–210, 2011. View at: Publisher Site | Google Scholar
  20. R. L. Chevalier, M. S. Forbes, and B. A. Thornhill, “Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy,” Kidney International, vol. 75, no. 11, pp. 1145–1152, 2009. View at: Publisher Site | Google Scholar
  21. J. Kim, K.-J. Jung, and K. M. Park, “Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury,” The American Journal of Physiology—Renal Physiology, vol. 298, no. 5, pp. F1118–F1129, 2010. View at: Publisher Site | Google Scholar
  22. T. Moriyama, N. Kawada, K. Nagatoya, M. Horio, E. Imai, and M. Hori, “Oxidative stress in tubulointerstitial injury: therapeutic potential of antioxidants towards interstitial fibrosis,” Nephrology Dialysis Transplantation, vol. 15, supplement 6, pp. 47–49, 2000. View at: Google Scholar
  23. O. García-Sánchez, F. J. López-Hernández, and J. M. López-Novoa, “An integrative view on the role of TGF-β in the progressive tubular deletion associated with chronic kidney disease,” Kidney International, vol. 77, no. 11, pp. 950–955, 2010. View at: Publisher Site | Google Scholar
  24. S. Oka and Y. Nakabeppu, “DNA glycosylase encoded by MUTYH functions as a molecular switch for programmed cell death under oxidative stress to suppress tumorigenesis,” Cancer Science, vol. 102, no. 4, pp. 677–682, 2011. View at: Publisher Site | Google Scholar
  25. Z. Sheng, S. Oka, D. Tsuchimoto et al., “8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair,” The Journal of Clinical Investigation, vol. 122, no. 12, pp. 4344–4361, 2012. View at: Publisher Site | Google Scholar

Copyright © 2015 Jianping Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

909 Views | 571 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.